Learn More
Medchemexpress LLC L-Leucine, N-[4-[(1H-imidazol-5-ylmethyl)amino]-2-(1-naphthalenyl)benzoyl]- | 191102-79-1 | 98.5% | 456.54 | 25 MG

Supplier: Medchemexpress LLC 25MGHY12369
GGTI-2133 is a peptidomimetic and a selective geranylgeranyltransferase I (GGTase-I) inhibitor with an IC50 of 38 nM. It exhibits 140-fold selectivity over farnesyltransferase (FTase) (IC50 of 5.4 μM). GGTI-2133 inhibits the geranylation of Rap-1A with an IC50 of 10 μM. It can be utilized for the study of eosinophilic airway inflammation, such as asthma.
- Selective geranylgeranyltransferase I (GGTase-I) inhibitor.
- Shows 140-fold selectivity over farnesyltransferase (FTase).
- Inhibits the geranylation of Rap-1A.
- Can be used for the study of eosinophilic airway inflammation such as asthma.
- Inhibits infiltration of inflammatory cells into airways in mouse experimental asthma (at 5 mg/kg; intraperitoneal injection; once a day; for 10 days).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.